Enfusion Inc Cl A (ENFN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | |||
| Net Income | 12,656 | N/A | N/A |
| Depreciation Amortization | 1,179 | N/A | N/A |
| Accounts receivable | -2,790 | N/A | N/A |
| Accounts payable and accrued liabilities | 231 | N/A | N/A |
| Other Working Capital | -1,798 | N/A | N/A |
| Other Operating Activity | 2,828 | 0 | 0 |
| Operating Cash Flow | $12,306 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||
| PPE Investments | -4,429 | N/A | N/A |
| Investing Cash Flow | $-4,429 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||
| Debt Issued | 29,700 | N/A | N/A |
| Debt Repayment | -2,000 | N/A | N/A |
| Common Stock Issued | 57,307 | N/A | N/A |
| Common Stock Repurchased | -57,450 | N/A | N/A |
| Other Financing Activity | -35,098 | 0 | 0 |
| Financing Cash Flow | $-7,541 | $N/A | $N/A |
| Exchange Rate Effect | -86 | N/A | N/A |
| Beginning Cash Position | 5,648 | N/A | N/A |
| End Cash Position | 5,898 | N/A | N/A |
| Net Cash Flow | $250 | $N/A | $N/A |
| Free Cash Flow | |||
| Operating Cash Flow | 12,306 | N/A | N/A |
| Capital Expenditure | -4,429 | N/A | N/A |
| Free Cash Flow | 7,877 | 0 | 0 |